Cartesian Therapeutics
RNAC
RNAC
96 hedge funds and large institutions have $103M invested in Cartesian Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 92 → 96 (+4)
4% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 26
0.06% more ownership
Funds ownership: 1.33% → 1.39% (+0.06%)
Holders
96
Holding in Top 10
2
Calls
$603K
Puts
$257K
Top Buyers
| 1 | +$5.81M | |
| 2 | +$1.42M | |
| 3 | +$1.18M | |
| 4 |
Two Sigma Investments
New York
|
+$1.16M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.01M |
Top Sellers
| 1 | -$3.28M | |
| 2 | -$1.69M | |
| 3 | -$1.37M | |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$1.33M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.1M |